Cargando…

BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis

BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC). Here, we evaluated the prognostic value of BT3.2 at the protein level in specimen from 199 HG-EOC patients. As the on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Page, Cécile, Marineau, Alexandre, Bonza, Patrick K., Rahimi, Kurosh, Cyr, Louis, Labouba, Ingrid, Madore, Jason, Delvoye, Nathalie, Mes-Masson, Anne-Marie, Provencher, Diane M., Cailhier, Jean-François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369854/ https://www.ncbi.nlm.nih.gov/pubmed/22685580 http://dx.doi.org/10.1371/journal.pone.0038541

Ejemplares similares

The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
por: Labouba, Ingrid, et al.
Publicado: (2014)

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
por: Le Page, Cécile, et al.
Publicado: (2019)

A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis
por: Communal, Laudine, et al.
Publicado: (2021)

Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
por: Le Page, Cécile, et al.
Publicado: (2010)

Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis
por: Tsofack, Serges P, et al.
Publicado: (2013)

RAN Nucleo-Cytoplasmic Transport and Mitotic Spindle Assembly Partners XPO7 and TPX2 Are New Prognostic Biomarkers in Serous Epithelial Ovarian Cancer
por: Cáceres-Gorriti, Katia Y., et al.
Publicado: (2014)

Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome
por: Gambaro, Karen, et al.
Publicado: (2015)

Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease
por: Fleury, Hubert, et al.
Publicado: (2015)

Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology
por: Vantourout, Pierre, et al.
Publicado: (2018)

Altered expression of Butyrophilin (BTN) and BTN‐like (BTNL) genes in intestinal inflammation and colon cancer
por: Lebrero‐Fernández, Cristina, et al.
Publicado: (2016)

PRP4K is a HER2-regulated modifier of taxane sensitivity
por: Corkery, Dale P, et al.
Publicado: (2015)

Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay
por: Labouba, Ingrid, et al.
Publicado: (2015)

New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity
por: Blazquez, Juan-Luis, et al.
Publicado: (2018)

Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer
por: Le Page, C, et al.
Publicado: (2006)

Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer
por: Létourneau, Isabelle J, et al.
Publicado: (2012)

The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome
por: Wojnarowicz, Paulina M., et al.
Publicado: (2012)

Btn3 is a negative regulator of Btn2-mediated endosomal protein trafficking and prion curing in yeast
por: Kanneganti, Vydehi, et al.
Publicado: (2011)

IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression
por: Péant, Benjamin, et al.
Publicado: (2016)

BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma
por: Lin, Yuansheng, et al.
Publicado: (2022)

Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours
por: Birch, Ashley H., et al.
Publicado: (2011)

Investigation of the intramolecular hydrogen bonding interactions and excited state proton transfer mechanism for both Br-BTN and CN-BTN systems
por: Yang, Dapeng, et al.
Publicado: (2019)

BMP-2 signaling in ovarian cancer and its association with poor prognosis
por: Le Page, Cécile, et al.
Publicado: (2009)

Ran GTPase: A Key Player in Tumor Progression and Metastasis
por: Boudhraa, Zied, et al.
Publicado: (2020)

Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease
por: Sauriol, Alexandre, et al.
Publicado: (2020)

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma
por: Bian, Benjamin, et al.
Publicado: (2019)

Comprehensive Analysis of the Prognostic Value and Immune Infiltration of Butyrophilin Subfamily 2/3 (BTN2/3) Members in Pan-Glioma
por: He, Dong, et al.
Publicado: (2022)

Prognostic and Therapeutic Significance of BTN3A Proteins in Tumors
por: Chen, Sihan, et al.
Publicado: (2021)

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
por: Fanale, Daniele, et al.
Publicado: (2022)

Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors
por: Ouellet, Véronique, et al.
Publicado: (2008)

Reply to Herrmann: The BTN3A isoform BTN3A1 is responsible for phosphoantigen-induced Vγ9Vδ2 T cell activation
por: Zhou, Jiaqing, et al.
Publicado: (2023)

Bioinformatics Training Network (BTN): a community resource for bioinformatics trainers
por: Schneider, Maria V., et al.
Publicado: (2012)

Caveat: Monoclonal antibodies 20.1 and 103.2 bind all human BTN3A proteins and are not suited to study BTN3A1-specific features
por: Herrmann, Thomas
Publicado: (2023)

Characterization of three new serous epithelial ovarian cancer cell lines
por: Ouellet, Véronique, et al.
Publicado: (2008)

Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro
por: Dery, Marie-Claude, et al.
Publicado: (2007)

Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion
por: Zaoui, Kossay, et al.
Publicado: (2019)

BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment
por: Kone, Abdou-samad, et al.
Publicado: (2022)

BTN2A2, a new biomarker and therapeutic target for glioma
por: Wang, Heping, et al.
Publicado: (2023)

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
por: Billon, Emilien, et al.
Publicado: (2021)

pH-dependent localization of Btn1p in the yeast model for Batten disease
por: Wolfe, Devin M., et al.
Publicado: (2011)

CRISPR/Cas9 in Leishmania mexicana: A case study of LmxBTN1
por: Ishemgulova, Aygul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pf80tf9bfd23b3ehqt3ptsotsi